The Cerebellum

, Volume 15, Issue 1, pp 48–50 | Cite as

Transplantation and Stem Cell Therapy for Cerebellar Degenerations

  • Jan CendelinEmail author


Stem cell-based and regenerative therapy may become a hopeful treatment for neurodegenerative diseases including hereditary cerebellar degenerations. Neurotransplantation therapy mainly aims to substitute lost cells, but potential effects might include various mechanisms including nonspecific trophic effects and stimulation of endogenous regenerative processes and neural plasticity. Nevertheless, currently, there remain serious limitations. There is a wide spectrum of human hereditary cerebellar degenerations as well as numerous cerebellar mutant mouse strains that serve as models for the development of effective therapy. By now, transplantation has been shown to ameliorate cerebellar function, e.g. in Purkinje cell degeneration mice, Lurcher mutant mice and mouse models of spinocerebellar ataxia type 1 and type 2 and Niemann-Pick disease type C. Despite the lack of direct comparative studies, it appears that there might be differences in graft development and functioning between various types of cerebellar degeneration. Investigation of the relation of graft development to specific morphological, microvascular or biochemical features of the diseased host tissue in various cerebellar degenerations may help to identify factors determining the fate of grafted cells and potential of their functional integration.


Ataxia Cerebellum Neurotransplantation Stem cell 



Supported by the Charles University Research Fund (project P36), by project CZ.1.05/2.1.00/ 03.0076 from the European Regional Development Fund and project COST No. LD12056 of the Ministry of Education, Youth and Sport of the Czech Republic. Many thanks belong to collaborators who have participated in the research.

Conflict of Interest

The author declares that he has no competing interests.


  1. 1.
    Boy J, Schmidt T, Wolburg H, Mack A, Nuber S, Böttcher M, et al. Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3. Hum Mol Genet. 2009;18:4282–95.CrossRefPubMedGoogle Scholar
  2. 2.
    Nobrega C, Nascimento-Ferreira I, Onofre I, Albuquerque D, Hirai H, Deglon N, et al. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. PLoS One. 2013;8, e52396.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Furrer SA, Waldherr SM, Mohanachandran MS, Baughn TD, Nguyen KT, Sopher BL, et al. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7. Hum Mol Genet. 2013;22:890–903.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Wang HL, Hu SH, Chou AH, Wang SS, Weng YH, Yeh TH. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse. Neuropharmacology. 2013;70:1–11.CrossRefPubMedGoogle Scholar
  5. 5.
    Chort A, Alves S, Marinello M, Dufresnois B, Dornbierer JG, Tesson C, et al. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice. Brain. 2013;136:1732–45.CrossRefPubMedGoogle Scholar
  6. 6.
    Rossi F, Cattaneo E. Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Nat Rev Neurosci. 2002;3:401–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Carletti B, Williams IM, Leto K, Nakajima K, Magrassi L, Rossi F. Time constraints and positional cues in the developing cerebellum regulate Purkinje cell placement in the cortical architecture. Dev Biol. 2008;317:147–60.CrossRefPubMedGoogle Scholar
  8. 8.
    Wu CY, Bao XF, Zhang C, Zhang QL. Fetal tissue grafts for cerebellar atrophy. Chin Med J. 1991;104:198–203.PubMedGoogle Scholar
  9. 9.
    Tian ZM, Chen T, Zhong N, Li ZC, Yin F, Liu S. Clinical study of transplantation of neural stem cells in therapy of inherited cerebellar atrophy. Beijing Da Xue Xue Bao. 2009;41:456–8.PubMedGoogle Scholar
  10. 10.
    Kaemmerer WF, Low WC. Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1. Exp Neurol. 1999;158:301–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Chintawar S, Hourez R, Ravella A, Gall D, Orduz D, Rai M, et al. Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model. J Neurosci. 2009;29:13126–35.CrossRefPubMedGoogle Scholar
  12. 12.
    Matsuura S, Shuvaev AN, Iizuka A, Nakamura K, Hirai H. Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1. Cerebellum. 2014;13:323–30.CrossRefPubMedGoogle Scholar
  13. 13.
    Chang YK, Chen MH, Chiang YH, Chen YF, Ma WH, Tseng CY, et al. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cell. J Biomed Sci. 2011;18:54.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Bae JS, Han HS, Youn DH, Carter JE, Modo M, Schuchman EH, et al. Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells. 2007;25:1307–16.CrossRefPubMedGoogle Scholar
  15. 15.
    Sotelo C, Alvarado-Mallart RM. Embryonic and adult neurons interact to allow Purkinje cell replacement in mutant cerebellum. Nature. 1987;327:421–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Triarhou LC, Zhang W, Lee WH. Amelioration of the behavioral phenotype in genetically ataxic mice through bilateral intracerebellar grafting of fetal Purkinje cells. Cell Transplant. 1996;5:269–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Dumesnil-Bousez N, Sotelo C. Partial reconstruction of the adult Lurcher cerebellar circuitry by neural grafting. Neuroscience. 1993;55:1–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Jones J, Jaramillo-Merchan J, Bueno C, Pastor D, Viso-Leon M, Martinez S. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis. 2010;40:415–23.CrossRefPubMedGoogle Scholar
  19. 19.
    Cendelin J, Babuska V, Korelusova I, Houdek Z, Vozeh F. Long-term survival of solid embryonic cerebellar grafts in lurcher mice. Neurosci Lett. 2012;515:23–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Babuska V, Houdek Z, Tuma J, Purkartova Z, Tumova J, Kralickova M, et al. Transplantation of embryonic cerebellar grafts improves gait parameters in ataxic lurcher mice. Cerebellum. 2015. doi: 10.1007/s12311-015-0656-x.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Pathophysiology, Faculty of Medicine in PilsenCharles University in PraguePlzenCzech Republic
  2. 2.Laboratory of Neurodegenerative Disorders, Biomedical Centre, Faculty of Medicine in PilsenCharles University in PraguePilsenCzech Republic

Personalised recommendations